Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 2
pubmed:dateCreated
2003-6-2
pubmed:abstractText
Opening of the mitochondrial permeability transition pore (MPTP) is thought to be a critical event in mediating the damage to hearts that accompanies their reperfusion following prolonged ischaemia. Protection from reperfusion injury occurs if the prolonged ischaemic period is preceded by short ischaemic periods followed by recovery. Here we investigate whether such ischaemic preconditioning (IPC) is accompanied by inhibition of MPTP opening. MPTP opening in Langendorff-perfused rat hearts was determined by perfusion with 2-deoxy[3H]glucose ([3H]DOG) and measurement of mitochondrial [3H]DOG entrapment. We demonstrate that IPC inhibits initial MPTP opening in hearts reperfused after 30 min global ischaemia, and subsequently enhances pore closure as hearts recover. However, MPTP opening in mitochondria isolated from IPC hearts occurred more readily than control mitochondria, implying that MPTP inhibition by IPC in situ was secondary to other factors such as decreased calcium overload and oxidative stress. Hearts perfused with cyclosporin A or sanglifehrin A, powerful inhibitors of the MPTP, also recovered better from ischaemia than controls (improved haemodynamic function and less lactate dehydrogenase release). However, the mitochondrial DOG entrapment technique showed these agents to be less effective than IPC at preventing MPTP opening. Our data suggest that protection from reperfusion injury is better achieved by reducing factors that induce MPTP opening than by inhibiting the MPTP directly.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10322501, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10355930, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10393078, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10508231, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10720416, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10728419, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10756123, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10802706, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-10869531, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11069928, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11073947, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11133228, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11158963, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11158992, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11245796, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11316512, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11322939, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11583991, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11588107, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11684066, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11701616, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-11788400, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-12022946, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-12095984, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-12154175, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-12160950, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-12482899, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-12562892, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-1811053, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-2160810, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-3663110, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-4327387, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-5118123, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-7512654, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-7717999, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-7758188, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-8679608, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-9013575, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-9309682, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-9352175, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-9535004, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-9660766, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-9714750, http://linkedlifedata.com/resource/pubmed/commentcorrection/12692185-9950850
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
549
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
513-24
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
pubmed:affiliation
Department of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
More...